A lawyer who is trying to broker a settlement in Johnson & Johnson’s baby powder cancer lawsuits proposed that it can resolve the decade-long litigation and any future cases for $19 billion — $10 billion more than the company offered …
Johnson & Johnson’s decision to phase out the talc-based version of its iconic baby powder may signal the company is moving out of litigation-defense mode over allegations the product causes cancer and preparing for a global settlement of almost 20,000 …
The U.S. Supreme Court reinforced its bar on lawsuits by patients against generic-drug makers, overturning a $21 million award to a woman who suffered debilitating injuries after taking a generic painkiller. The justices, voting 5-4, said the federal drug-approval regime …